10x Genomics, Inc. TXG Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Spatial | $40.91M+30.9% | $40.96M+14.4% | $35.37M+19.2% | $36.4M+24.4% | $31.25M+18.3% | |
| Revenue by Geography | ||||||
| Americas (excluding United States) | $3.41M-9.2% | $3.22M+9.6% | $2.63M-15.3% | $2.67M-22.0% | $3.75M-6.0% | |
| Asia-Pacific (excluding China) | $18.06M+16.2% | $15.37M+15.0% | $12.32M+12.5% | $8.85M-0.8% | $15.54M+22.0% | |
| China | $15.84M-6.2% | $15.02M+2.8% | $15.19M+1.1% | $23.17M+68.7% | $16.88M+21.3% | |
| Europe, Middle East and Africa | $36.85M+15.5% | $53.46M+7.3% | $41.62M+10.0% | $34.73M-7.0% | $31.9M-8.1% | |
| United States | $76.69M-11.7% | $78.96M-6.3% | $77.25M-8.8% | $103.49M+15.4% | $86.82M+14.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does 10x Genomics, Inc. break its business down?
- 10x Genomics, Inc. (TXG) reports total revenue by product across 2 parts — Single Cell and Spatial. Each is extracted from the segment footnotes and tracked over time.
- Where does 10x Genomics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in 10x Genomics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
